San Diego-based ResMed has won a key victory in a patent infringement case against a Chinese medical-device manufacturer.

A ResMed sleep apnea mask. Courtesy ResMed
A ResMed sleep apnea mask. Courtesy ResMed

The International Trade Commission ruled just before Christmas that sleep apnea masks made by BMC Medical Co. Ltd. infringe ResMed’s patents. The independent federal agency prohibited BMC from importing, advertising or selling four mask models in the United States.

“Changing lives with every breath is the foundation of ResMed’s business. That focus drives our patient-centric approach to research and development. It’s why our products are the highest quality and the most comfortable, and it’s why we vigorously protect our patent portfolio,” said David Pendarvis, ResMed chief administrative officer and global general counsel.

“We are pleased the court has validated ResMed’s intellectual property rights protecting those valuable innovations for the benefit of patients.”

ResMed has a portfolio of more than 5,000 patents, pending patent applications and protected designs on flow generators, humidifiers and masks relating to sleep therapy.

Chris Jennewein is Editor & Publisher of Times of San Diego.